Compare RYTM & WING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RYTM | WING |
|---|---|---|
| Founded | 2008 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 6.7B |
| IPO Year | 2017 | 2015 |
| Metric | RYTM | WING |
|---|---|---|
| Price | $89.56 | $186.29 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 28 |
| Target Price | $129.07 | ★ $338.78 |
| AVG Volume (30 Days) | 735.8K | ★ 1.0M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.63% |
| EPS Growth | 28.34 | ★ 67.84 |
| EPS | N/A | ★ 6.21 |
| Revenue | N/A | ★ $696,853,000.00 |
| Revenue This Year | $57.46 | $18.23 |
| Revenue Next Year | $85.60 | $16.31 |
| P/E Ratio | ★ N/A | $30.73 |
| Revenue Growth | N/A | ★ 11.35 |
| 52 Week Low | $45.91 | $189.23 |
| 52 Week High | $122.20 | $388.14 |
| Indicator | RYTM | WING |
|---|---|---|
| Relative Strength Index (RSI) | 43.94 | 31.44 |
| Support Level | $85.59 | N/A |
| Resistance Level | $96.26 | $267.86 |
| Average True Range (ATR) | 4.73 | 11.80 |
| MACD | -0.09 | -4.12 |
| Stochastic Oscillator | 54.73 | 2.44 |
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
Founded in 1994 in Garland, Texas, Wingstop is a restaurant operator specializing in indulgent bone-in and boneless chicken wings, chicken tenders, fries, and, recently, chicken sandwiches. The firm's footprint has grown quickly since its inception, expanding to 2,932 global stores at the end of the third quarter of 2025. With a 98% franchised model, Wingstop generates the lion's share of its revenue from franchise royalties and advertising fees, with the remainder derived from a small footprint of company-owned stores.